Background
==========

Syndromic surveillance is used widely by public health departments to detect and monitor unusual disease activity in the population by extracting nonspecific clinical data from information systems in clinical settings \[[@B1]-[@B4]\]. Whereas much syndromic surveillance practice \[[@B3]\] and research \[[@B5]\] has focused on visits to emergency departments (ED), visits to community clinics offer another promising source of data. Syndromes followed in practice, such as influenza-like-illness (ILI), typically involve earlier, milder stages of disease, and most affected persons are likely to self-treat \[[@B6]-[@B8]\], at least initially, or present to walk-in clinics \[[@B6]\]. In fact, researchers have demonstrated that excess ILI activity can be detected earlier using data from clinics as compared to data from EDs \[[@B9]-[@B11]\]. The accuracy of diagnostic data from community clinics has not, however, been established.

Many syndromic surveillance systems use International Classification of Disease, 9^th^revision (ICD-9) diagnostic codes in administrative databases to monitor syndrome occurrence \[[@B12]\]. For this purpose, expert panels have generated groupings of ICD-9 codes corresponding to conceptual syndrome definitions \[[@B13]\]. Administrative databases offer great promise for population-based surveillance by providing access to diagnostic information from many sites, including community healthcare settings. However, unlike medical procedure codes, ICD-9 diagnostic codes are not usually linked to healthcare provider payment, and therefore are not audited by health administrative authorities. Because of this, variation in diagnostic coding between physicians and between institutions is expected.

In a pilot study \[[@B14]\], we evaluated the accuracy of diagnostic codes in physician claims for identifying acute respiratory infections in nine Montreal-area community-based physicians. We abstracted the diagnosis from the medical chart for the 3,526 visits made by 729 sampled patients in 2002-2005, and compared the medical chart diagnosis to the ICD-9 code on the corresponding physician claim. For all acute respiratory infections combined, we found a sensitivity of 0.49, 95% CI (0.45, 0.53), and a positive predictive value (PPV) of 0.93, 95% CI (0.91, 0.94). These pilot study results are promising, but there is a need for a large-scale, population-based investigation of the accuracy of diagnostic codes used in syndromic surveillance.

The objective of the present study was to assess the accuracy of syndrome definitions based on diagnostic codes from a representative sample of physician claims for identifying 5 syndromes (fever, gastrointestinal, neurological, rash, and respiratory, including influenza-like illness (ILI)) in community healthcare settings. These syndromes were selected for their relevance to public health and the likelihood of being first detected among patients presenting to community healthcare settings.

Methods
=======

Context
-------

This study was conducted in the province of Quebec, Canada, where universal health coverage is provided through the provincial health insurance plan. Each Canadian province maintains a population-based registry of insured persons and claims for all physician visits remunerated on a fee-for-service basis. Physician claims include information on the diagnosis (recorded as an ICD-9 code), medical procedure, visit date, location, and cost of service. All claims also record unique physician and patient identifiers that can be used to create longitudinal histories of healthcare use. In the province of Quebec, 99% of residents have provincial health insurance and 85-95% of medical visits are remunerated on a fee-for-service basis \[[@B15]\]. In 2006, there were more than 7.6 million inhabitants in Quebec \[[@B16]\], and 18,908 active registered physicians \[[@B17]\]. The availability of diagnostic information for nearly all medical visits to Quebec physicians represents an invaluable opportunity for assessing the validity of using diagnostic codes in physician claims for population-based surveillance, including syndromic surveillance.

Study design and sampling
-------------------------

The accuracy of diagnostic codes in physician claims for identifying syndromes was assessed by comparison to clinical information in the corresponding medical chart. To ensure representativeness, we used a population-based, 3-stage stratified random sample of 36,000 visits (Figure [1](#F1){ref-type="fig"}). In the first stage (Figure [1](#F1){ref-type="fig"} Stage 1), the provincial health insurance agency identified all physicians who were eligible to be included in our study. To be eligible, physicians had to be a general practitioner, pediatrician, internist, geriatrician or general surgeon who practiced in the fee-for-service system in a private clinic, community health center, or hospital-based ambulatory care clinic during the 2-year study period (October 1, 2005 to September 30, 2007). Internists and general surgeons were included in our sample because, especially in rural-remote and underserved areas, these physicians may provide first-contact care and act as patients\' family physician. From the 8,700 eligible physicians identified, the provincial health insurance agency selected a random sample of 3,600 (41.4%) physicians.

![**Population-based, 3-stage stratified random sample of visits to all community physicians in the province of Quebec**.](1471-2458-11-17-1){#F1}

In the second stage (Figure [1](#F1){ref-type="fig"} Stage 2), to facilitate chart retrieval for review, the health insurance agency randomly selected one eligible community practice location for each physician. The health insurance agency then sent the research team an anonymized file containing all physician claims billed by the 3,600 physicians from their respective selected community practice location during the 2-year study period (Figure [2](#F2){ref-type="fig"} Step 1).

![Overview of data collection\
\* Physician sampling by the Quebec health insurance agency is described in Figure 1, Stages 1 and 2.\
\*\* Visit sampling by the research team is described in Figure 1, Stage 3.](1471-2458-11-17-2){#F2}

In the third stage (Figure [1](#F1){ref-type="fig"} Stage 3), the research team randomly selected 5 syndrome-positive visits, i.e., 1 visit for each of fever, gastrointestinal, neurological, rash, and respiratory syndrome (including ILI), and 5 visits negative for all syndromes. Visits were classified as positive for a syndrome if a physician claim for the visit had an ICD-9 code that was part of the syndrome definition. Because syndromes have low population prevalence, to maximize data collection efficiency \[[@B18]\], syndrome-positive visits were over-sampled relative to syndrome-negative ones, so as to yield 1 syndrome-positive visit per syndrome per physician and 5 syndrome-negative visits per physician. When sampling syndrome-positive claims, to maximize the number of syndrome-positive ICD-9 codes verified, we further stratified on ICD-9 code. Because two or more syndromes can occur concurrently in the same patient \[[@B19]\], syndrome-negative visits were negative for *all*syndromes. Syndrome-negative visits were also matched to syndrome-positive visits on calendar month to avoid bias due to syndrome seasonality. To avoid bias due to visits being clustered within patients, restriction was used to ensure that each patient was only sampled once. The list of 10 sampled visits was enumerated for each of the 3,600 physicians, for a total of 36,000 visits. An anonymized unique identifier, the study number, was assigned to each sampled visit by the research team. The list of 36,000 sampled visits was then sent to the health insurance agency (Figure [2](#F2){ref-type="fig"} Step 2).

Syndrome definitions
--------------------

We verified two sets of definitions for the 5 syndromes under study: the definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003 \[[@B13]\], and used by the US Department of Defense\'s (DoD) Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE), as well as the corresponding definitions in the University of Pittsburgh\'s Real-time Outbreak and Disease Surveillance (RODS) system \[[@B19]\]. For ILI, we used the large-group (sensitive) and small-group (specific) definitions developed for the DoD ESSENCE system \[[@B20]\]. These definitions are similar to the consensus syndrome definitions being developed by representatives from the 10 syndromic surveillance systems in place in the US \[[@B21]\], which have not yet been mapped to ICD-9 codes.

Physician recruitment
---------------------

To preserve physician and patient anonymity, the health insurance agency sent the list of 3,600 physicians and 36,000 visits sampled by the research team to the medical regulatory authority (Figure [2](#F2){ref-type="fig"} Step 3). The medical regulatory authority has the legal right to access confidential physician and patient information, therefore the list it received included physician names and mailing addresses, as well as patient names, insurance numbers, and dates of birth. The medical regulatory authority acted as a trusted third party and recruited physicians to the study on behalf of the research team; it also provided physicians with information on the 10 sampled visits (Figure [2](#F2){ref-type="fig"} Step 4). Interested physicians mailed their written consent and contact information to the research team (Figure [2](#F2){ref-type="fig"} Step 5). Non-responding physicians were sent up to four reminders. Physician recruitment began in September 2008 and ended in August 2009. To maximize participation, physicians were offered \$50 compensation for their participation and a summary of study findings.

Physician-facilitated medical chart review
------------------------------------------

The medical regulatory authority sent each physician the list of 10 sampled visits (Figure [2](#F2){ref-type="fig"} Step 3). Lists sent to physicians included patients\' first and last names, date of birth, health insurance number, and date of the visit to be verified, as well as the study number for each visit. Because the lists sent to physicians contained both patient information and study numbers, it enabled physicians to retrieve the relevant medical charts, and researchers to link the information collected through chart review to the anonymized physician claims file. During the chart review, interviewers and physicians referred to each visit using only the study number and visit date, thereby preserving patient anonymity.

Physician-facilitated medical chart reviews began in September 2008 and ended in December 2009. Using a previously published methodology \[[@B22]\], trained interviewers contacted consenting physicians by telephone to perform the chart review (Figure [2](#F2){ref-type="fig"} Step 6). For each of the 10 sampled visits, the interviewer asked the physician to list all diagnoses. For each diagnosis corresponding to a syndrome definition, the interviewer asked the physician about the signs, symptoms, and key findings recorded in the medical chart, as well as the most likely etiology for the diagnosis (based solely on information available at the time of the visit).

Physician responses were entered directly into a database by the interviewer. Diagnoses were selected from a searchable list of diagnoses (mapped to ICD-9 codes) or, if the physician had recorded the ICD-9 code in the medical chart, the ICD-9 code was entered directly. For each syndrome-positive diagnosis, a list of syndrome-specific signs and symptoms was elicited, and the interviewer recorded whether the sign or symptom had been present, absent, or not recorded in the medical chart. Symptoms or signs not in the list and other key findings, such as epidemiologic links to other diagnosed cases or known outbreaks, were recorded as free text in separate fields. The data collection tool was translated to French for use with French-speaking physicians, and back-translated to English to ensure comparability of data collection.

At the time of chart review, the physician and interviewer were both blinded to the ICD-9 code in the physician claim and the syndrome-positive or syndrome-negative status of the claim. To minimize measurement error due to inter-rater differences, interviewers were trained to use the data collection tool. Inter-rater reliability was assessed at baseline by having interviewers perform 2 simulated physician interviews of 10 visits each (for a total of 20 visits). To maintain data quality, interviewers underwent quality assurance monitoring every 3 months. Each assessment was comprised of 2 simulated physician interviews of 10 visits each (for a total of 20 visits). Agreement between raters was measured using the intraclass correlation coefficient (ICC).

Linkage of the medical chart review data to the physician claims data
---------------------------------------------------------------------

The database containing the medical chart review data was linked to the physician claims file using the study number, physician identifier, and visit date. In our pilot study \[[@B14]\], we found that the visit date in the chart sometimes differed slightly from the visit date on the claim. We considered the chart and the claim to refer to the same visit if the visit date in the chart was within 0 (identical date) to 3 days from the visit date in the claim.

Physician characteristics that may influence participation
----------------------------------------------------------

Physician gender, preferred language (French or English), specialty, practice setting, and geographic location were obtained from the health insurance agency. Physician year of licensure was obtained from the medical regulatory authority. The number of days worked per year was calculated as the number of days when at least one claim was billed by the physician to the health insurance agency. The number of patients seen per day worked was calculated as the number of distinct patients for which one or more claim was billed by the physician per day worked. The number and prevalence of syndrome-positive visits were calculated for each physician using claims billed from the selected practice location during the 2-year study period.

Statistical methods
-------------------

For each visit, we assessed if the ICD-9 code in the physician claim and the diagnosis in the corresponding medical chart agreed as to the presence of each syndromes and ILI. For example, if the diagnosis in the claim was cough (786.2) and the diagnosis in the corresponding medical chart was acute bronchitis (466.0), then both the claim diagnosis and the chart diagnosis were positive for respiratory syndrome, therefore the claim was a true-positive for respiratory syndrome. If the diagnosis in the claim was cough (786.2) and the diagnoses in the chart were hypertension (401.9) and diabetes (250.0), then the claim diagnosis was positive for respiratory syndrome and the chart diagnoses were not, therefore the claim was a false-positive for respiratory syndrome.

The negative predictive value (NPV) of each syndrome definition was estimated directly from the data. Because we stratified syndrome-positive visits by ICD-9 code, we had to use an adjustment based on Bayes Theorem \[[@B23]\] to estimate the PPV of each syndrome. The PPV was estimated as a weighted average of each ICD-9 code\'s PPV, the weight being the number of visits with a given ICD-9 code divided by the total number of visits positive for that syndrome among participating physicians.

Because we verified more syndrome-positive visits than syndrome-negative ones, direct estimation of sensitivity and specificity using our data would lead to verification bias: sensitivity would be overestimated, and specificity underestimated \[[@B23]\]. Because verified claims were randomly sampled within syndrome-positive and syndrome-negative strata, unbiased estimation of these parameters was achieved by re-weighting for the verification fractions \[[@B23]\]. The sensitivity and specificity of physician claims for identifying each syndrome was estimated from the PPV and NPV \[[@B24]\] using the correction for verification bias \[[@B23]\], re-weighting for the different sampling fractions. We estimated the 95% CI for the bias-corrected sensitivity and specificity using the methods described by Begg and Greenes \[[@B23]\].

Ethics review
-------------

The research protocol for this study was reviewed and approved by the McGill University Institutional Review Board, the Quebec privacy commission (Commission d\'accès à l\'information du Québec), the legal department of the Quebec health insurance agency (Régie de l\'assurance maladie du Québec), and the Quebec medical regulatory authority (Collège des médecins du Québec).

Results
=======

Between October 1, 2005 and September 30, 2007, the 3,600 study physicians billed for over 20 million visits by 4.8 million patients (61% of the province\'s population) from their randomly selected community practice.

Physician participation
-----------------------

Of 3,600 physicians contacted, 172 (4.8%) had an incorrect address on file with the health insurance agency, and 170 (4.7%) were discovered to be ineligible (recently deceased, retired, on sick/maternity leave, no longer practicing at the selected practice location). Of the 3,258 remaining physicians, 1,129 (34.7%) physicians consented to participate in the study, 218 (6.7%) refused, and 1,911 (58.7%) did not respond. Of the 1,129 consenting physicians, 1,098 (97.3%) completed the physician-facilitated medical chart review, and 31 (2.7%) were unreachable or withdrew consent prior to interview. Participating and non-participating physicians were similar on all measured variables except two (Table [1](#T1){ref-type="table"}): as compared to non-participants, participants had been in practice longer and had worked more days during the study period. Syndrome prevalence was similar among participating and non-participating physicians, and ranged from 5 per 1,000 visits for neurological syndrome and ILI small-group, to 126 per 1,000 visits for respiratory syndrome.

###### 

Characteristics of participating and non-participating physicians

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                     Participating physicians (N = 1,098)   Non-participating physicians (N = 2,160)                         
  -------------------------------------------------- -------------------------------------- ------------------------------------------ --------------------- -------------------------
  **Physician characteristics**                      **No**.                                **(%)**                                    **No**.               **(%)**

                                                                                                                                                             

  Gender:                                                                                                                                                    

   Female                                            411                                    37.4                                       823                   38.1

   Male                                              687                                    62.6                                       1,337                 61.9

  Preferred language:                                                                                                                                        

   French                                            1,006                                  91.6                                       1,937                 89.7

   English                                           92                                     8.4                                        223                   10.3

  Specialty:                                                                                                                                                 

   General practice                                  993                                    90.4                                       1,932                 89.4

   Internal medicine                                 13                                     1.2                                        41                    1.9

   Pediatrics                                        62                                     5.6                                        102                   4.7

   General surgery                                   30                                     2.7                                        85                    3.9

   Geriatrics                                        0                                      0                                          0                     0

  Type of setting selected:^1^                                                                                                                               

   Private clinic                                    1,060                                  96.5                                       2,044                 94.6

   Community health center                           5                                      0.5                                        9                     0.4

   Hospital-based\                                   33                                     3.0                                        107                   5.0
  ambulatory clinic                                                                                                                                          

  Geographic location of selected setting:^1,3^                                                                                                              

    Urban                                            921                                    83.9                                       1,867                 86.4

    Rural                                            177                                    16.1                                       293                   13.6

                                                     **Mean**                               **SD**                                     **Mean**              **SD**

  Years since licensure                              24.2                                   9.7                                        22.3                  10.5

  No. days worked per year^1^                        157.0                                  55.0                                       143.2                 59.8

  No. patients seen per day worked^1^                21.2                                   13.4                                       21.0                  13.3

                                                                                                                                                             

  **Syndrome frequency based on claim ICD-9 code**   **No. visits**^1,2^                    **Prevalence**\                            **No. visits**^1,2^   **Prevalence**\
                                                                                            **per 1,000 visits**^1^                                          **per 1,000 visits**^1^

                                                                                                                                                             

  *CDC and DoD ESSENCE^4^*                                                                                                                                   

   Fever                                             80,884                                 11                                         160,821               12

   Gastrointestinal                                  162,282                                22                                         309,209               24

   Neurological                                      40,236                                 5                                          73,810                6

   Rash                                              126,900                                17                                         224,370               17

   Respiratory                                       911,924                                125                                        1,643,240             126

  *RODS^5^*                                                                                                                                                  

   Fever                                             162,000                                22                                         291,990               22

   Gastrointestinal                                  146,355                                20                                         283,578               22

   Neurological                                      36,344                                 5                                          67,344                5

   Rash                                              55,251                                 8                                          103,698               8

   Respiratory                                       478,201                                65                                         877,556               67

  *Influenza-like illness^6^*                                                                                                                                

   Large-group                                       622,046                                85                                         1,129,782             87

   Small-group                                       32,173                                 4                                          61,127                5
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^ As per our study design, for each physician, a single practice location was randomly selected to facilitate the validation process. The information in this table is based in claims generated from the selected practice location during the 2-year study period.

^2^There were a total of 7,315,994 visits to the 1,098 participating physicians, and 13,010,410 visits to the 2,160 eligible non-participating physicians at the selected practice location during the 2-year study period.

^3^We tested the statistical significance (at the p \< 0.05 level) of any differences between participating and non-participating physicians using a multivariate logistic regression model where the dependent variable was participation and the independent variables were all characteristics in Table 1. Due to overlap between CDC, RODS, and ILI syndrome definitions, to avoid collinearity, we used separate models for each set of syndrome definitions. As compared to non-participating physicians, participating physicians had been in practice longer (odds ratio (OR)~per\ 10\ years\ since\ licensure~, 1.15; 95% CI, 1.05-1.25), had worked more days (OR~per\ 50\ days~, 1.18; 95% CI, 1.09-1.28) during the 2-year study period.

^4^Syndrome case definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003, and used by the US Department of Defense\'s Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).

^5^Syndrome case definitions developed in the context of the University of Pittsburgh\'s Real-time Outbreak and Disease Surveillance (RODS) system.

^6^Syndrome case definitions developed in the context of the US Department of Defense\'s Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).

Inter-rater agreement
---------------------

Agreement between raters was measured using simulated physician interviews shortly before the start of data collection and every 3 months thereafter. Agreement was perfect on all assessments (ICC = 1.00).

Date agreement between the claim and the medical chart
------------------------------------------------------

Of the 10,980 visits selected for verification (10 visits per participating physician), physicians were able to access the corresponding medical chart for 10,669 (97.2%). The most common reasons for being unable to access the chart were inability to locate the medical chart (151 charts) and medical chart in storage with retrieval fee (140 charts). For 10,465 (98.1%) of the sampled visits, the visit date in the medical chart was identical to the visit date on the claim. Allowing for potential date transcription errors during billing, an additional 64 (0.6%) visits with a date in the medical chart that was within 1-3 days of the visit date on the claim were identified, for a total of 10,529 visits for which both the medical chart and the claim was available and the visit dates were in agreement (within the 3 day time window).

Syndrome agreement between the claim ICD-9 code and the medical chart diagnosis
-------------------------------------------------------------------------------

Table [2](#T2){ref-type="table"} shows the accuracy of ICD-9 codes in physician claims for identifying syndromes, as compared to the medical chart. The sensivity of ICD-9 codes in physician claims for identifying syndromes was low, ranging from 0.11, 95% CI (0.10, 0.13) for fever syndrome to 0.44, 95% CI (0.41, 0.47) for respiratory syndrome. The PPV of ICD-9 codes in physician claims for identifying syndromes was moderate to high, ranging from 0.59, 95% CI (0.55, 0.64) for fever syndrome to 0.85, 95% CI (0.83, 0.88) for respiratory syndrome. Both the specificity and NPV of ICD-9 codes in physician claims were near-perfect for all syndromes studied.

###### 

Accuracy of ICD-9 coded diagnoses in physician claims, as compared to ICD-9 coded diagnoses from physician-facilitated medical chart review, for identifying constitutional, gastrointestinal, neurological, rash, and respiratory syndrome, as well as influenza-like illness (ILI) (N = 10,529 visits with matched claim-record pair)

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Syndrome definition               **No**.\                    **No**.\                    Sensivity (95% CI)   Specificity (95% CI)   PPV (95% CI)        NPV (95% CI)
                                    visits in verified claims   visits in verified charts                                                                   
  --------------------------------- --------------------------- --------------------------- -------------------- ---------------------- ------------------- -------------------
  ***CDC and DoD ESSENCE^1^***                                                                                                                              

   Fever                            601                         656                         0.11 (0.10, 0.13)    0.99 (0.99, 0.99)      0.59 (0.55, 0.64)   0.94 (0.93, 0.95)

   Gastrointestinal                 855                         888                         0.23 (0.20, 0.26)    0.99 (0.99, 0.99)      0.71 (0.66, 0.75)   0.94 (0.94, 0.95)

   Neurological                     971                         693                         0.17 (0.14, 0.21)    1.00 (1.00, 1.00)      0.67 (0.64, 0.70)   0.98 (0.98, 0.98)

   Rash                             897                         905                         0.20 (0.18, 0.23)    0.99 (0.99, 0.99)      0.66 (0.62, 0.70)   0.95 (0.95, 0.96)

   Respiratory                      1,049                       1,779                       0.44 (0.41, 0.47)    0.97 (0.96, 0.98)      0.85 (0.83, 0.88)   0.84 (0.83, 0.85)

                                                                                                                                                            

  ***RODS^2^***                                                                                                                                             

   Fever                            873                         961                         0.14 (0.12, 0.16)    0.99 (0.99, 0.99)      0.60 (0.56, 0.64)   0.91 (0.90, 0.92)

   Gastrointestinal                 703                         834                         0.20 (0.18, 0.23)    0.99 (0.99, 0.99)      0.68 (0.63, 0.73)   0.94 (0.94, 0.95)

   Neurological                     874                         523                         0.16 (0.13, 0.20)    1.00 (1.00, 1.00)      0.52 (0.48, 0.55)   0.99 (0.98, 0.99)

   Rash                             814                         718                         0.12 (0.10, 0.14)    1.00 (1.00, 1.00)      0.63 (0.59, 0.66)   0.96 (0.96, 0.97)

   Respiratory                      665                         1,209                       0.29 (0.26, 0.32)    0.98 (0.98, 0.98)      0.74 (0.70, 0.79)   0.87 (0.86, 0.88)

                                                                                                                                                            

  ***Influenza-like illness^3^***                                                                                                                           

   Large-group                      653                         1,232                       0.38 (0.35, 0.41)    0.98 (0.98, 0.98)      0.77 (0.73, 0.81)   0.88 (0.87, 0.89)

   Small-group                      53                          49                          0.18 (0.12, 0.26)    1.00 (1.00, 1.00)      0.29 (0.16, 0.41)   0.99 (0.99, 0.99)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^Syndrome case definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003, and used by the US Department of Defense\'s Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).

^2^Syndrome case definitions developed in the context of the University of Pittsburgh\'s Real-time Outbreak and Disease Surveillance (RODS) system.

^3^Syndrome case definitions developed in the context of the US Department of Defense\'s Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).

Additional file [1](#S1){ref-type="supplementary-material"} (excerpted in Table [3](#T3){ref-type="table"}) shows the PPV of physician claims for identifying syndromes for each ICD-9 code individually. There was wide variation in PPV between different ICD-9 codes in a given syndrome. ICD-9 codes that were very rarely used by physicians, for example tularemia (ICD-9 code: 21.9), had a high probability of being false-positives, and therefore a very low PPV. ICD-9 codes for common symptoms, for example fever (ICD-9 code: 780.6), had a lower probability of being false-positives, and a higher PPV. ICD-9 codes that represent common diagnoses, for example acute bronchitis (ICD-9 code: 466.0), had the lowest probability of being false-positives, and the highest PPV.

###### 

Example of diagnostic codes with the highest and lowest positive predictive value (excerpted from additional file 1)

  *Example of diagnostic codes with the HIGHEST positive predictive value (PPV)*                                                                                 
  ----------------------------------------------------------------------------------- ---------------- --------------------------------------------------------- -------------------
  **Syndrome**                                                                        **ICD-9 code**   **Diagnostic label**                                      **PPV (95% CI)**
                                                                                                                                                                 
  Fever^1^                                                                            82.8             Tick-borne rickettsiosis not elsewhere classified         1.00 (1.00, 1.00)
                                                                                      88.8             Other specified arthropod-borne diseases                  1.00 (1.00, 1.00)
                                                                                                                                                                 
  Gastrointestinal^1^                                                                 7.1              Giardiasis                                                1.00 (1.00, 1.00)
                                                                                      5.9              Food poisoning not otherwise specified                    1.00 (1.00, 1.00)
                                                                                                                                                                 
  Neurological^1^                                                                     323.0            Encephalitis in viral disease classified elsewhere        1.00 (1.00, 1.00)
                                                                                      784.3            Aphasia                                                   1.00 (1.00, 1.00)
                                                                                                                                                                 
  Rash^1^                                                                             53.8             Herpes zoster with unspecified complication               1.00 (1.00, 1.00)
                                                                                      695.2            Erythema nodosum                                          1.00 (1.00, 1.00)
                                                                                                                                                                 
  Respiratory^1^                                                                      33.0             *Bordetella pertussis*                                    1.00 (1.00, 1.00)
                                                                                      462.9            Pharyngitis, acute not otherwise specified                1.00 (1.00, 1.00)
                                                                                                                                                                 
  ILI large-group^2^                                                                  487.0            Influenza with pneumonia                                  1.00 (1.00, 1.00)
                                                                                      486.0            Pneumonia, organism not otherwise specified               1.00 (1.00, 1.00)
                                                                                                                                                                 
  ***Example of diagnostic codes with the LOWEST positive predictive value (PPV)***                                                                              
                                                                                                                                                                 
  **Syndrome**                                                                        **ICD-9 code**   **Diagnostic label**                                      **PPV (95% CI)**
                                                                                                                                                                 
  Fever^1^                                                                            88.0             Bartonellosis                                             0.00 (0.00, 0.00)
                                                                                      78.2             Sweating fever                                            0.00 (0.00, 0.00)
                                                                                                                                                                 
  Gastrointestinal^1^                                                                 555.0            Regional enteritis, small intestine                       0.00 (0.00, 0.00)
                                                                                      1.1              Cholera due to *Vibrio cholerae*El Tor                    0.00 (0.00, 0.00)
                                                                                                                                                                 
  Neurological^1^                                                                     323.2            Encephalitis in protozoal disease classified elsewhere    0.00 (0.00, 0.00)
                                                                                      53.0             Herpes zoster with meningitis                             0.00 (0.00, 0.00)
                                                                                                                                                                 
  Rash^1^                                                                             51.0             Cowpox                                                    0.00 (0.00, 0.00)
                                                                                      55.8             Measles complications not otherwise specified             0.00 (0.00, 0.00)
                                                                                                                                                                 
  Respiratory^1^                                                                      20.4             Secondary pneumonic plague                                0.00 (0.00, 0.00)
                                                                                      79.8             Hantavirus infection                                      0.00 (0.00, 0.00)
                                                                                                                                                                 
  ILI large-group^2^                                                                  490.0            Bronchitis not otherwise specified                        0.00 (0.00, 0.00)
                                                                                      465.8            Acute upper respiratory infection, other multiple sites   0.36 (0.08, 0.65)

^1^Syndrome case definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003, and used by the US Department of Defense\'s Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).

^2^Syndrome case definition developed in the context of the US Department of Defense\'s Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).

Discussion
==========

This study was the first large-scale, population-based investigation of the accuracy of syndrome definitions based on diagnostic codes in physician claims from community healthcare settings. We found that the sensitivity of syndrome definitions based on diagnostic codes in physician claims for identifying syndromes was low, the PPV was moderate to high, and the specificity and NPV were near-perfect. Even though our sensitivity estimates were low for all syndromes definitions, these syndrome definitions may still be useful for monitoring syndrome occurrence when there are large numbers of cases (e.g., seasonal influenza). Respiratory syndrome had the highest prevalence and was the most accurately reported in physician claims. Unexpectedly, ILI small-group had the lowest PPV of all syndromes definitions studied, much lower than previously reported by others \[[@B20]\]. The small-group definition of ILI is made up of only four ICD-9 codes: influenza with pneumonia (487.0), influenza with other respiratory manifestations (487.1), influenza with other manifestations (487.8), and acute upper respiratory infection, other multiple sites (465.8). Based on our interviews of over a thousand community physicians, we think that the poor accuracy of the ILI small-group definition reflects the common usage of the word \'flu\' to describe a vague illness or a combination of non-specific symptoms. In addition to observing variation in physician claim accuracy between syndromes, we also found large variation in accuracy and prevalence between diagnostic codes within syndromes. Diagnostic codes with a very low prevalence were generally more likely to be false-positives; conversely, diagnostic codes with a higher prevalence were generally less likely to be false-positives, especially if they represented a diagnosis, as opposed to a symptom. This suggests that physicians are more likely to know the correct diagnostic code for a frequently diagnosed ailment, as compared to a rare one.

Rigorous attempts to assess the accuracy of ICD-9 codes used in syndromic surveillance as compared to the medical chart have been few, and they have relied on small convenience samples of emergency departments. In one such study, the accuracy of ICD-9 codes in ED reports for identifying 3 syndromes (fever, gastrointestinal, and respiratory) was assessed as compared to hospital chart diagnoses in the context of the US DoD ESSENCE surveillance system \[[@B25]\]. For greater data collection efficiency, syndrome-positive ED reports were over-sampled relative to syndrome-negative ones; however, analyses were not adjusted for this differential sampling strategy, resulting in verification bias \[[@B23]\], and leading to a large overestimation of sensivity and underestimation of specificity. To illustrate, the proportion of fever-positive visits in the sample was 0.19, whereas the proportion of fever-positive visits in the population is approximately 0.01 (based on our study). The authors reported a sensitivity of 0.69 and a specificity of 0.95. However, adjusting for verification bias, the estimates would be approximately 0.09 for sensivity and 1.00 for specificity, which is similar to our results. In another study, the accuracy of ICD-9 codes in ED reports for identifying 7 syndrome definitions (botulinic, constitutional, gastrointestinal, hemorrhagic, neurological, rash, and respiratory) was assessed against hospital chart diagnoses in the context of the RODS surveillance system \[[@B19]\]. To maximize the quantity of syndrome-positive ICD-9 codes verified, the investigators selected a random sample of syndrome-positive visits from ED reports, stratified on syndrome-positive ICD-9 code, such that an equal number of syndrome-positive visits was sampled for each ICD-9 code in a syndrome. For example, fever (780.6) and bubonic plague (020.0), both corresponding to constitutional syndrome, contributed the same number of cases. However, the prevalence and accuracy of each ICD-9 code in a syndrome is different, and because the analyses were not adjusted for the uniform sampling strategy used, the reported estimates of sensitivity, specificity, PPV and NPV are biased. In a third study \[[@B26]\], the accuracy of ICD-9 coded physician diagnoses from 9 hospital EDs for identifying \'acute respiratory illness\' was assessed by comparison to medical chart review. A simple random sample was used; therefore the results were not subject to verification bias. The authors reported a sensitivity of 0.43, 95% CI (0.28-0.58) for acute respiratory illness, which is almost identical to our sensitivity estimate for respiratory syndrome; their estimates of NPV and specificity were also similar to ours, but their PPV estimate of 0.45, 95% CI (0.29-0.61) is much lower than ours.

Our study had several strengths and limitations. We used a large population-based random sample of all physicians working in the fee-for-service system in community healthcare settings in the province of Quebec in 2005-2007, thereby capturing potential ICD-9 coding differences between physicians, institutions, and regions. Not only did we estimate the accuracy of syndrome definitions, as others have done, but our study design enabled us to estimate the PPV of individual diagnostic codes within each syndrome definition. Matching syndrome-negative visits to syndrome-positive visit on calendar month ensured that our results were not affected by seasonal bias. Because two or more syndromes can occur concurrently in the same person \[[@B19]\], our requirement that syndrome-negative visits be negative for all syndromes ensured that we did not overestimate false-negatives and underestimate sensitivity and NPV. Our participation rate, though low, was consistent with that of other large population-based studies of Canadian physicians \[[@B27],[@B28]\]. Participating and non-participating physicians were similar on nearly all measured variables. The participation rate was significantly lower among recently licensed physicians; recently licensed physicians may have been less likely to participate in our study because they tend to experience greater practice mobility \[[@B29]\] and report more impediments to practice \[[@B30]\] than their more experienced counterparts. Unfortunately, the accuracy of very rare syndrome-positive ICD-9 codes, such as cutaneous and pulmonary anthrax (22.0 and 22.1), could not be estimated because, as expected, they were not present in any of the 1,098 participating physicians\' claims during the 2-year study period.

Conclusions
===========

We found that diagnostic codes in physician claims from community healthcare settings have low sensitivity, moderate to high PPV, and near-perfect specificity and NPV for identifying 5 syndromes (fever, gastrointestinal, neurological, rash, and respiratory, including ILI). Future research should evaluate the practical implications of our findings on decision-making in response to alerts from existing syndromic surveillance systems. Future research should also identify physician, patient, and encounter characteristics associated with better accuracy of diagnostic codes in physician claims. This would enable public health to improve syndromic surveillance, either by focusing on physician claims whose diagnostic code is more likely to be accurate, or by using all physician claims and weighing each according to the likelihood that its diagnostic code is accurate. We also estimated the prevalence and PPV of individual diagnostic codes within each syndrome. We found that rarely used diagnostic codes had a higher probability of being false-positives, and that more commonly used diagnostic codes had a higher PPV. These findings may be useful to the ongoing development of sensitive and specific consensus syndrome definitions, as either a sensitive or a specific definition may be more useful depending on the surveillance objective.
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